Skip to main content
Erschienen in: Archives of Osteoporosis 1/2020

01.12.2020 | Original Article

The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis

verfasst von: Qiang Gao, Chi Zhang, Jianxiong Wang, Qingchuan Wei, Quan Wei, Akira Miyamoto, Siyi Zhu, Chengqi He

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Summary

Research on osteoporosis is a well-developed and promising research field. The top 100 literature included 73 articles and 27 reviews. The average citation number was 747 (range 370 to 2970). Researchers and institutions from the USA, the UK, and France contributed the most to the top high-cited articles.

Purpose

To provide a bibliometric and visualized analysis of the top 100 highly cited articles on osteoporosis indexed by the Web of Science (WoS) from 1990 to 2019.

Methods

Data were obtained from the WoS Core Collection on Jan 10, 2020. Qualitative and quantitative analysis was conducted based on WoS. Collaboration analysis and keywords analysis were performed using VosView software.

Results

A total of 12,863 references were obtained. The top 100 highly cited literature included 73 articles and 27 reviews. The average citation number of the 100 articles was 747 (range 370 to 2970). The fund sources mostly came from the USA. A total of 29 journals published the top 100 highly cited literature. The New England Journal of Medicine had the largest number of papers and the highest total cited times. The USA published 72 articles. The University of California San Francisco published 17 articles, followed by University of Sheffield and Mayo Clinic and Mayo Foundation. Cooper C had the most publications (n = 12) and Genant HK had the largest total citation (n = 11,055). Considering only the first author and corresponding author, Kanis JA had published the most articles. Researchers and institutions from the USA, the UK, and France contributed the most to the top high-cited articles.

Conclusions

Research on osteoporosis is a well-developed and promising research field. The top 100 articles have been cited widely and actively. New England Journal of Medicine was the most popular journal. The most productive country was the USA. The University of California San Francisco, University of Sheffield, and Mayo Clinic and Mayo Foundation were the most productive institutions. Cooper C, Kanis JA, and Genant HK were the most prolific and influential authors. Researchers and institutions from North America and Europe contributed the most.
Literatur
1.
Zurück zum Zitat Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364–376CrossRef Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364–376CrossRef
2.
Zurück zum Zitat Imai T, Tanaka S, Kawakami K, Miyazaki T, Hagino H, Shiraki M, Group ATR (2017) Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial. Osteoporos Int 28:1893–1901CrossRef Imai T, Tanaka S, Kawakami K, Miyazaki T, Hagino H, Shiraki M, Group ATR (2017) Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial. Osteoporos Int 28:1893–1901CrossRef
3.
Zurück zum Zitat Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182CrossRef Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182CrossRef
4.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis- related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis- related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRef
5.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136CrossRef Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136CrossRef
6.
Zurück zum Zitat Cooper ID (2015) Bibliometrics basics. J Med Libr Assoc 103:217–218CrossRef Cooper ID (2015) Bibliometrics basics. J Med Libr Assoc 103:217–218CrossRef
7.
Zurück zum Zitat Moed HF (2009) New developments in the use of citation analysis in research evaluation. Arch Immunol Ther Exp 57:13–18CrossRef Moed HF (2009) New developments in the use of citation analysis in research evaluation. Arch Immunol Ther Exp 57:13–18CrossRef
8.
Zurück zum Zitat Gu W, Yuan Y, Yang H, Qi G, Jin X, Yan J (2015) A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis 10:667–676 Published 2015 Mar 25PubMedPubMedCentral Gu W, Yuan Y, Yang H, Qi G, Jin X, Yan J (2015) A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis 10:667–676 Published 2015 Mar 25PubMedPubMedCentral
9.
Zurück zum Zitat Shuaib W, Costa JL (2015) Anatomy of success: 100 most cited articles in diabetes research. Ther Adv Endocrinol Metab 6:163–173CrossRef Shuaib W, Costa JL (2015) Anatomy of success: 100 most cited articles in diabetes research. Ther Adv Endocrinol Metab 6:163–173CrossRef
10.
Zurück zum Zitat Shuaib W, Khan MS, Shahid H, Valdes EA, Alweis R (2015) Bibliometric analysis of the top 100 cited cardiovascular articles. Am J Cardiol 115:972–981CrossRef Shuaib W, Khan MS, Shahid H, Valdes EA, Alweis R (2015) Bibliometric analysis of the top 100 cited cardiovascular articles. Am J Cardiol 115:972–981CrossRef
11.
Zurück zum Zitat Yin X, Cheng F, Wang X, Mu J, Ma C, Zhai C, Wang Q (2019) Top 100 cited articles on rheumatoid arthritis: a bibliometric analysis. Medicine (Baltimore) 98:e14523CrossRef Yin X, Cheng F, Wang X, Mu J, Ma C, Zhai C, Wang Q (2019) Top 100 cited articles on rheumatoid arthritis: a bibliometric analysis. Medicine (Baltimore) 98:e14523CrossRef
12.
Zurück zum Zitat Pluskiewicz W, Drozdzowska B, Adamczyk P, Noga K (2018) Scientific output quality of 40 globally top-ranked medical researchers in the field of osteoporosis. Arch Osteoporos 13:35CrossRef Pluskiewicz W, Drozdzowska B, Adamczyk P, Noga K (2018) Scientific output quality of 40 globally top-ranked medical researchers in the field of osteoporosis. Arch Osteoporos 13:35CrossRef
13.
Zurück zum Zitat Qiu Y, Yang W, Wang Q, Yan S, Li B, Zhai X (2018) Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 13:121CrossRef Qiu Y, Yang W, Wang Q, Yan S, Li B, Zhai X (2018) Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 13:121CrossRef
14.
Zurück zum Zitat Sweileh WM, Al-Jabi SW, Zyoud SH, Sawalha AF, Ghanim MA (2014) Osteoporosis is a neglected health priority in Arab World: a comparative bibliometric analysis. Springerplus 3:427CrossRef Sweileh WM, Al-Jabi SW, Zyoud SH, Sawalha AF, Ghanim MA (2014) Osteoporosis is a neglected health priority in Arab World: a comparative bibliometric analysis. Springerplus 3:427CrossRef
15.
Zurück zum Zitat AlRyalat SAS, Malkawi LW, Momani SM (2019) Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. J Vis Exp 24(152) AlRyalat SAS, Malkawi LW, Momani SM (2019) Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. J Vis Exp 24(152)
16.
Zurück zum Zitat NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef
17.
Zurück zum Zitat Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRef Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRef
18.
Zurück zum Zitat Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645CrossRef Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645CrossRef
19.
Zurück zum Zitat Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443CrossRef Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443CrossRef
20.
Zurück zum Zitat Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268CrossRef Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268CrossRef
21.
Zurück zum Zitat Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344–1352CrossRef Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344–1352CrossRef
22.
Zurück zum Zitat Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822CrossRef Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822CrossRef
23.
Zurück zum Zitat Cummings SR, San Martin J, McClung MR et al (2009) FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765CrossRef Cummings SR, San Martin J, McClung MR et al (2009) FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765CrossRef
24.
Zurück zum Zitat Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137 ReviewPubMed Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137 ReviewPubMed
25.
Zurück zum Zitat Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305–311 ReviewCrossRef Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305–311 ReviewCrossRef
26.
Zurück zum Zitat Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936 ReviewCrossRef Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936 ReviewCrossRef
27.
Zurück zum Zitat Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83–91CrossRef Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83–91CrossRef
28.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4:368–381CrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4:368–381CrossRef
29.
Zurück zum Zitat Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468CrossRef Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468CrossRef
30.
Zurück zum Zitat Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371CrossRef Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371CrossRef
31.
Zurück zum Zitat Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259–264CrossRef Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259–264CrossRef
32.
Zurück zum Zitat O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018CrossRef O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018CrossRef
33.
Zurück zum Zitat Del Giudice M (2016) How well do bibliometric indicators correlate with scientific eminence? A comment on Simonton. Perspect Psychol Sci Del Giudice M (2016) How well do bibliometric indicators correlate with scientific eminence? A comment on Simonton. Perspect Psychol Sci
34.
Zurück zum Zitat La Torre G, Sciarra I, Chiappetta M, Monteduro A (2017) New bibliometric indicators for the scientific literature: an evolving panorama. Clin Ter 168:e65–e71PubMed La Torre G, Sciarra I, Chiappetta M, Monteduro A (2017) New bibliometric indicators for the scientific literature: an evolving panorama. Clin Ter 168:e65–e71PubMed
35.
Zurück zum Zitat Brüggmann D, Mäule LS, Klingelhöfer D, Schöffel N, Gerber A, Jaque JM, Groneberg DA (2016) World-wide architecture of osteoporosis research:density-equalizing mapping studies and gender analysis. Climacteric 19:463–470CrossRef Brüggmann D, Mäule LS, Klingelhöfer D, Schöffel N, Gerber A, Jaque JM, Groneberg DA (2016) World-wide architecture of osteoporosis research:density-equalizing mapping studies and gender analysis. Climacteric 19:463–470CrossRef
36.
Zurück zum Zitat Ioannidis JP, Klavans R, Boyack KW (2016) Multiple citation indicators and their composite across scientific disciplines. PLoS Biol 14:e1002501CrossRef Ioannidis JP, Klavans R, Boyack KW (2016) Multiple citation indicators and their composite across scientific disciplines. PLoS Biol 14:e1002501CrossRef
37.
Zurück zum Zitat Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276–1287CrossRef Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276–1287CrossRef
Metadaten
Titel
The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis
verfasst von
Qiang Gao
Chi Zhang
Jianxiong Wang
Qingchuan Wei
Quan Wei
Akira Miyamoto
Siyi Zhu
Chengqi He
Publikationsdatum
01.12.2020
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2020
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-0705-z

Weitere Artikel der Ausgabe 1/2020

Archives of Osteoporosis 1/2020 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.